You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《盈警響號》阿里健康(00241.HK)料中績轉蝕最多3.2億人民幣
阿思達克 10-26 04:02
阿里健康(00241.HK)發盈警,與上年同期淨利潤22.79億人民幣相比,預計9月止六個月錄得虧損淨額不多於3.2億人民幣。綜合因素包括集團增加資源配置以投入一系列創新業務如「醫鹿」APP、健康險等;在藥品倉儲物流等藥品供應鏈能力以及醫藥自營業務,技術研發持續投入;在天貓醫藥平台和阿里健康大藥房品牌心智建設加大投入;因提升線上B2C藥品銷售市佔率、加速處方藥業務佈局並增加相應市場投放帶來的自營業務利潤率降低;及部分被投資允價值變動產生的未變現收益增加所抵銷。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
uSMART
Wealth Growth Made Easy
Open Account